About this episode

This episode explores the evidence and arguments surrounding curcumin's effects on blood sugar and mood, highlighting both benefits and limitations.

Explore the 2026 meta-analysis and supporting studies on curcumin for prediabetes, type 2 diabetes, depression, and anxiety, weighing compelling arguments in favor of its use against important limitations and counterpoints. We break down benefits like improved glycemic control and mood support alongside bioavailability issues, study flaws, safety concerns, and why it’s no miracle cure. This balanced episode includes a layman’s summary, real-world example, and practical guidance for anyone considering turmeric or supplements

Topics covered

• curcumin
• turmeric
• blood sugar
• mood support
• diabetes
• mental health

Keywords

• curcumin
• turmeric
• blood sugar
• mood
• diabetes
• depression
• anxiety
• meta-analysis
• supplements

Mentioned in this episode

Products: Curcumin, Turmeric

Places: prediabetes, type 2 diabetes, depression, anxiety

More episodes of Pharmacology News

• Noribogaine (DMX-1001): A Neuroplastogen Breakthrough for Alcohol Use Disorder or Another Psychedelic Promise with Risks? · June 1, 2026 · 5 min
• Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications · May 27, 2026 · 5 min
• The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2 · May 26, 2026 · 5 min
• The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1 · May 25, 2026 · 4 min
• Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy? · May 20, 2026 · 7 min
• Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions · May 15, 2026 · 8 min

Explore listener stats, chart rankings, contacts and more on the Pharmacology News podcast page.